ReOx Ltd
Company Details |
|
|---|---|
| Name: | ReOx Ltd |
| Year of Creation: | 2003 |
| Research Sector: | Life Sciences |
| Company Sector: | Drug Discovery |
| University Partner: | University of Oxford |
| Company Type: | Private |
| Company Description | |
|---|---|
| Description: | ReOx is a drug discovery company which aims to develop novel treatments for disease by controlling the activity of hypoxia inducible factor (HIF). The importance of HIF activity has been demonstrated in a wide range of important diseases, ranging from heart disease to cancer; treatments for which have a market value of over $70bn. Drugs that can control HIF activity are likely to be of immense commercial interest to this market. |
| Contact details: | Dr Barry Porter, Chief Executive Officer ReOx Limited Magdalen Centre Robert Robinson Avenue The Oxford Science Park Oxford OX4 4GA United Kingdom Tel: +44 (0)1865 784422 Fax: +44 (0)1865 784425 |
| Website: |  www.reox.co.uk |
